{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T01:23:27Z","timestamp":1766712207626,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12014-017-9140-6","type":"journal-article","created":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T17:09:57Z","timestamp":1484672997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A new enzyme-linked immunosorbent assay (ELISA) for human free and bound kallikrein 9"],"prefix":"10.1186","volume":"14","author":[{"given":"Panagiota","family":"Filippou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Korbakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Farkona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoninus","family":"Soosaipillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theano","family":"Karakosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1589-820X","authenticated-orcid":false,"given":"Eleftherios P.","family":"Diamandis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,17]]},"reference":[{"key":"9140_CR1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1158\/1541-7786.257.2.5","volume":"2","author":"CA Borgono","year":"2004","unstructured":"Borgono CA, Michael IP, Diamandis EP. Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res. 2004;2:257\u201380.","journal-title":"Mol Cancer Res"},{"key":"9140_CR2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrd4534","volume":"14","author":"I Prassas","year":"2015","unstructured":"Prassas I, Eissa A, Poda G, Diamandis EP. Unleashing the therapeutic potential of human kallikrein-related serine proteases. Nat Rev Drug Discov. 2015;14:183\u2013202.","journal-title":"Nat Rev Drug Discov"},{"key":"9140_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408363.2016.1154643","volume":"53","author":"PS Filippou","year":"2016","unstructured":"Filippou PS, Karagiannis GS, Musrap N, Diamandis EP. Kallikrein-related peptidases (KLKs) and the hallmarks of cancer. Crit Rev Clin Lab Sci. 2016;53:1\u201358.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"9140_CR4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/geno.2000.6159","volume":"65","author":"GM Yousef","year":"2000","unstructured":"Yousef GM, Diamandis EP. The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9). Genomics. 2000;65:184\u201394.","journal-title":"Genomics"},{"key":"9140_CR5","first-page":"184","volume":"22","author":"GM Yousef","year":"2001","unstructured":"Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev. 2001;22:184\u2013204.","journal-title":"Endocr Rev"},{"key":"9140_CR6","first-page":"7811","volume":"61","author":"GM Yousef","year":"2001","unstructured":"Yousef GM, Kyriakopoulou LG, Scorilas A, Fracchioli S, et al. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker. Cancer Res. 2001;61:7811\u20138.","journal-title":"Cancer Res"},{"key":"9140_CR7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1022931403825","volume":"78","author":"GM Yousef","year":"2003","unstructured":"Yousef GM, Scorilas A, Nakamura T, Ellatif MA, et al. The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer. Breast Cancer Res Treat. 2003;78:149\u201358.","journal-title":"Breast Cancer Res Treat"},{"key":"9140_CR8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1186\/s12885-015-1566-5","volume":"15","author":"KL Drucker","year":"2015","unstructured":"Drucker KL, Gianinni C, Decker PA, Diamandis EP, et al. Prognostic significance of multiple kallikreins in high-grade astrocytoma. BMC Cancer. 2015;15:565.","journal-title":"BMC Cancer"},{"key":"9140_CR9","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1515\/BC.2008.158","volume":"389","author":"JL Shaw","year":"2008","unstructured":"Shaw JL, Diamandis EP. Regulation of human tissue kallikrein-related peptidase expression by steroid hormones in 32 cell lines. Biol Chem. 2008;389:1409\u201319.","journal-title":"Biol Chem"},{"key":"9140_CR10","doi-asserted-by":"crossref","first-page":"e1617","DOI":"10.1097\/MD.0000000000001617","volume":"94","author":"AM Blazquez-Medela","year":"2015","unstructured":"Blazquez-Medela AM, Garcia-Sanchez O, Quiros Y, Blanco-Gozalo V, et al. Increased Klk9 urinary excretion is associated to hypertension-induced cardiovascular damage and renal alterations. Medicine (Baltimore). 2015;94:e1617.","journal-title":"Medicine (Baltimore)"},{"key":"9140_CR11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12864-015-1508-2","volume":"16","author":"M Keermann","year":"2015","unstructured":"Keermann M, Koks S, Reimann E, Prans E, et al. Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN. BMC Genom. 2015;16:322.","journal-title":"BMC Genom"},{"issue":"347\u20139","key":"9140_CR12","first-page":"e6","volume":"114","author":"FU Nasim","year":"2015","unstructured":"Nasim FU, Ejaz S, Ashraf M, Ahmad S. Human tissue kallikrein 9 in asthmatic patients. Ann Allergy Asthma Immunol. 2015;114(347\u20139):e6.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"9140_CR13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/ac00028a004","volume":"64","author":"TK Christopoulos","year":"1992","unstructured":"Christopoulos TK, Diamandis EP. Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates. Anal Chem. 1992;64:342\u20136.","journal-title":"Anal Chem"},{"key":"9140_CR14","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1074\/mcp.M114.047571","volume":"14","author":"D Korbakis","year":"2015","unstructured":"Korbakis D, Brinc D, Schiza C, Soosaipillai A, et al. Immunocapture-selected reaction monitoring screening facilitates the development of ELISA for the measurement of native TEX101 in biological fluids. Mol Cell Proteomics. 2015;14:1517\u201326.","journal-title":"Mol Cell Proteomics"},{"key":"9140_CR15","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1074\/jbc.M608348200","volume":"282","author":"CA Borgono","year":"2007","unstructured":"Borgono CA, Michael IP, Shaw JL, Luo LY, et al. Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14. J Biol Chem. 2007;282:2405\u201322.","journal-title":"J Biol Chem"},{"key":"9140_CR16","first-page":"3958","volume":"63","author":"GM Yousef","year":"2003","unstructured":"Yousef GM, Polymeris ME, Grass L, Soosaipillai A, et al. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. Cancer Res. 2003;63:3958\u201365.","journal-title":"Cancer Res"},{"key":"9140_CR17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1515\/BC.2006.092","volume":"387","author":"N Memari","year":"2006","unstructured":"Memari N, Grass L, Nakamura T, Karakucuk I, et al. Human tissue kallikrein 9: production of recombinant proteins and specific antibodies. Biol Chem. 2006;387:733\u201340.","journal-title":"Biol Chem"},{"key":"9140_CR18","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1373\/clinchem.2007.088104","volume":"53","author":"JL Shaw","year":"2007","unstructured":"Shaw JL, Diamandis EP. Distribution of 15 human kallikreins in tissues and biological fluids. Clin Chem. 2007;53:1423\u201332.","journal-title":"Clin Chem"},{"key":"9140_CR19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jprot.2014.11.004","volume":"114","author":"D Korbakis","year":"2015","unstructured":"Korbakis D, Prassas I, Brinc D, Batruch I, et al. Delineating monoclonal antibody specificity by mass spectrometry. J Proteomics. 2015;114:115\u201324.","journal-title":"J Proteomics"},{"key":"9140_CR20","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1074\/mcp.M115.057695","volume":"15","author":"TD Karakosta","year":"2016","unstructured":"Karakosta TD, Soosaipillai A, Diamandis EP, Batruch I, et al. Quantification of human kallikrein-related peptidases in biological fluids by multi-platform targeted mass spectrometry assays. Mol Cell Proteomics. 2016;15:2863\u201376.","journal-title":"Mol Cell Proteomics."},{"key":"9140_CR21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/2048872613486249","volume":"2","author":"MP Bonaca","year":"2013","unstructured":"Bonaca MP, Ruff CT, Kosowsky J, Conrad MJ, et al. Evaluation of the diagnostic performance of current and next-generation assays for cardiac troponin I in the BWH-TIMI ED Chest Pain Study. Eur Heart J Acute Cardiovasc Care. 2013;2:195\u2013202.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"9140_CR22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1373\/49.1.77","volume":"49","author":"C Kapadia","year":"2003","unstructured":"Kapadia C, Chang A, Sotiropoulou G, Yousef GM, et al. Human kallikrein 13: production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay. Clin Chem. 2003;49:77\u201386.","journal-title":"Clin Chem"},{"key":"9140_CR23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1097-0045(19980101)34:1<44::AID-PROS6>3.0.CO;2-K","volume":"34","author":"SD Mikolajczyk","year":"1998","unstructured":"Mikolajczyk SD, Millar LS, Kumar A, Saedi MS. Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors. Prostate. 1998;34:44\u201350.","journal-title":"Prostate"},{"key":"9140_CR24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0167-4781(03)00116-7","volume":"1628","author":"GM Yousef","year":"2003","unstructured":"Yousef GM, Kapadia C, Polymeris ME, Borgono C, et al. The human kallikrein protein 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors in ovarian cancer fluids. Biochim Biophys Acta. 2003;1628:88\u201396.","journal-title":"Biochim Biophys Acta"},{"key":"9140_CR25","first-page":"3315","volume":"19","author":"N Kioukia-Fougia","year":"1999","unstructured":"Kioukia-Fougia N, Christofidis I, Strantzalis N. Physicochemical conditions affecting the formation\/stability of serum complexes and the determination of prostate-specific antigen (PSA). Anticancer Res. 1999;19:3315\u201320.","journal-title":"Anticancer Res"},{"key":"9140_CR26","first-page":"222","volume":"51","author":"UH Stenman","year":"1991","unstructured":"Stenman UH, Leinonen J, Alfthan H, Rannikko S, et al. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res. 1991;51:222\u20136.","journal-title":"Cancer Res"},{"key":"9140_CR27","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/ijc.1501","volume":"94","author":"MS Saedi","year":"2001","unstructured":"Saedi MS, Zhu Z, Marker K, Liu RS, et al. Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells. Int J Cancer. 2001;94:558\u201363.","journal-title":"Int J Cancer"},{"key":"9140_CR28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.biochi.2015.09.023","volume":"122","author":"M Kalinska","year":"2016","unstructured":"Kalinska M, Meyer-Hoffert U, Kantyka T, Potempa J. Kallikreins\u2014the melting pot of activity and function. Biochimie. 2016;122:270\u201382.","journal-title":"Biochimie"},{"key":"9140_CR29","first-page":"295","volume":"62","author":"EP Diamandis","year":"2002","unstructured":"Diamandis EP, Okui A, Mitsui S, Luo LY, et al. Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma. Cancer Res. 2002;62:295\u2013300.","journal-title":"Cancer Res"},{"key":"9140_CR30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1373\/49.1.87","volume":"49","author":"T Kishi","year":"2003","unstructured":"Kishi T, Grass L, Soosaipillai A, Shimizu-Okabe C, et al. Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids. Clin Chem. 2003;49:87\u201396.","journal-title":"Clin Chem"},{"key":"9140_CR31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1373\/clinchem.2003.029538","volume":"50","author":"T Kishi","year":"2004","unstructured":"Kishi T, Soosaipillai A, Grass L, Little SP, et al. Development of an immunofluorometric assay and quantification of human kallikrein 7 in tissue extracts and biological fluids. Clin Chem. 2004;50:709\u201316.","journal-title":"Clin Chem"},{"key":"9140_CR32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/clinchem\/47.2.237","volume":"47","author":"LY Luo","year":"2001","unstructured":"Luo LY, Grass L, Howarth DJ, Thibault P, et al. Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues. Clin Chem. 2001;47:237\u201346.","journal-title":"Clin Chem"},{"key":"9140_CR33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-5347(17)35408-3","volume":"150","author":"A Christensson","year":"1993","unstructured":"Christensson A, Bjork T, Nilsson O, Dahlen U, et al. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. J Urol. 1993;150:100\u20135.","journal-title":"J Urol"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-017-9140-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T22:45:09Z","timestamp":1658443509000},"score":1,"resource":{"primary":{"URL":"http:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/s12014-017-9140-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,17]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["9140"],"URL":"https:\/\/doi.org\/10.1186\/s12014-017-9140-6","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"type":"print","value":"1542-6416"},{"type":"electronic","value":"1559-0275"}],"subject":[],"published":{"date-parts":[[2017,1,17]]},"article-number":"4"}}